[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569186":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":56,"collaborators":60,"id":62,"slug":10,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":10,"eligibilityCriteria":66,"healthyVolunteers":67,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":74,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":83,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group Assignment",null,"Each subject receive a single intravenous injection of 68Ga\u002F18F-PSMA\u002FPSFA, and undergo PET\u002FCT imaging within the specificed time.",[13],"Diagnostic Test: 68Ga\u002F18F-PSMA\u002FPSFA",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","68Ga\u002F18F-PSMA\u002FPSFA",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Haonan Yu, MD","CONTACT","+8613821000597","dreamadam@126.com",[26,44],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"The First Affiliated Hospital of University of Science and Technology of China","RECRUITING","Hefei","Anhui","230000","China",{"type":34,"coordinates":35},"Point",[36,37],117.28083,31.86389,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":42,"phoneExt":10,"email":43},"Qiang Xie, PhD","+8613721108043","ahxq1980@163.com",{"facility":45,"status":28,"city":46,"state":47,"zip":48,"country":32,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Tianjin Medical University General Hospital","Tianjin","Tianjin Municipality","300052",{"type":34,"coordinates":50},[51,52],117.17667,39.14222,{"lat":52,"lon":51},[55],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Shaobo Yao, PhD","Prof.",[61],{"name":45,"class":6},"100569186",false,"NCT06690970","Prostate Specific Membrane Antigen PET\u002FCT Imaging in PSMA-Related Disease Patients","Inclusion Criteria:\n\n\\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled PSMA PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n\\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":72,"type":73},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 68Ga\u002F18F-PSMA\u002FPSFA positron emission tomography\u002Fcomputed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various PSMA-related disease patients.",[78,79,80,81,82],"PSMA-related Disease","Prostate Cancer","Positron Emission Tomography","Metastasis","FAP",[84,85,82],"PET\u002FCT","PSMA","2025-08-07",{"date":88,"type":89},"2025-08-11","ACTUAL",{"date":91,"type":89},"2020-09-01",{"date":93,"type":73},"2027-12-01",{"name":5,"class":6},2]